Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 3

C2. Bone and joint

Session: New Developments in Antibiotic Efficacy

108 - Efficacy of Dalbavancin Compared to Standard of Care for the Treatment of Osteomyelitis: A Retrospective Study

On Demand
Participants should be aware of the following financial/non-financial relationships:
Alexander Cain, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Derek N. Bremmer, PharmD, BCPS-AQ ID : I do not have any relevant financial / non-financial relationships with any proprietary interests.
Dustin R. Carr, PharmD, BCPS, BCIDP, AAHIVP: Merck (Speaker's Bureau)
Carley Buchanan, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Max Jacobs, DO: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thomas L. Walsh, MD: Accelerate Diagnostics (Other Financial or Material Support, speaking fees)
Matthew Moffa, DO: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nathan R. Shively, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tamara Trienski, PharmD, BCIDP: I do not have any relevant financial / non-financial relationships with any proprietary interests.

    Presenting Author(s)

  • Alexander Cain, PharmD

    Clinical Pharmacy Specialist, Infectious Diseases
    Allegheny Health Network
    Towson, MD, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    Slides Slides and Audio

    • Co-Author(s)

  • DB

    Derek N. Bremmer, PharmD, BCPS-AQ ID

    Clinical Pharmacy Specialist
    Allegheny Health Network
    pittsburgh, PA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • DC

    Dustin R. Carr, PharmD, BCPS, BCIDP, AAHIVP

    Clinical Pharmacy Specialist
    Allegheny Health Network
    Pittsburgh, PA, United States

    Merck (Speaker's Bureau)

  • CB

    Carley Buchanan, PharmD

    Clinical Pharmacy Specialist
    Allegheny Health Network
    pittsburgh, PA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • MJ

    Max Jacobs, DO

    Allegheny Health Network
    Pittsburgh, Pennsylvania, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • TW

    Thomas L. Walsh, MD

    Attending Physician
    Allegheny Health Network
    Pittsburgh, PA, United States

    Accelerate Diagnostics (Other Financial or Material Support, speaking fees)

  • MM

    Matthew Moffa, DO

    Attending Physician
    Allegheny Health Network
    PIttsburgh, PA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Nathan R. Shively, MD

    Medical Director, Antimicrobial Stewardship Program, Allegheny Valley Hospital
    Allegheny Health Network
    Pittsburgh, PA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • TT

    Tamara Trienski, PharmD, BCIDP

    Clinical Pharmacy Specialist, Infectious Diseases
    Allegheny General Hospital
    Pittsburgh, Pennsylvania, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.